CASELLA, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 389
EU - Europa 311
AS - Asia 197
AF - Africa 27
SA - Sud America 22
OC - Oceania 1
Totale 947
Nazione #
US - Stati Uniti d'America 370
DE - Germania 81
SE - Svezia 78
CN - Cina 75
IT - Italia 74
SG - Singapore 42
HK - Hong Kong 30
GB - Regno Unito 21
BG - Bulgaria 19
BR - Brasile 18
CI - Costa d'Avorio 17
IN - India 17
JP - Giappone 12
FR - Francia 11
CA - Canada 10
RU - Federazione Russa 9
SN - Senegal 8
TR - Turchia 8
CR - Costa Rica 6
FI - Finlandia 6
VN - Vietnam 5
GR - Grecia 3
IR - Iran 3
PL - Polonia 3
BH - Bahrain 2
CL - Cile 2
MX - Messico 2
RS - Serbia 2
AU - Australia 1
BE - Belgio 1
EG - Egitto 1
ET - Etiopia 1
GT - Guatemala 1
ID - Indonesia 1
IE - Irlanda 1
IQ - Iraq 1
KR - Corea 1
LT - Lituania 1
NO - Norvegia 1
PE - Perù 1
VE - Venezuela 1
Totale 947
Città #
Ashburn 54
Santa Clara 40
Chandler 29
Hong Kong 29
Ann Arbor 28
Woodbridge 25
Fairfield 24
Singapore 24
Shanghai 22
Sofia 19
Abidjan 17
Beijing 15
Boulder 15
Florence 14
New York 14
Frankfurt am Main 10
Princeton 9
Boardman 8
Dakar 8
Houston 8
Lawrence 8
Istanbul 7
Munich 7
Cambridge 6
Ottawa 6
Redwood City 6
Rome 6
San José 6
Seattle 6
Tokyo 6
Wilmington 6
Des Moines 5
Los Angeles 5
Mumbai 5
Nanjing 5
Serra 5
Dong Ket 4
Helsinki 4
Matsudo 4
Medford 4
Parma 4
Dearborn 3
Hefei 3
London 3
Milan 3
Montale 3
Pisa 3
Roubaix 3
Washington 3
Bari 2
Belgrade 2
Bremen 2
Changsha 2
Fuzhou 2
Lauterbourg 2
Manama 2
Montreal 2
Naples 2
Napoli 2
Norwalk 2
Portsmouth 2
Quanzhou 2
San Giorgio a Liri 2
Scafati 2
Seveso 2
Shenyang 2
Shenzhen 2
Tehran 2
Tianjin 2
Toronto 2
Anchorage 1
Atlanta 1
Auroville 1
Belo Horizonte 1
Bexley 1
Bodio Lomnago 1
Brasília 1
Brussels 1
Caracas 1
Casa Nova 1
Chicago 1
Chongqing 1
Contagem 1
Council Bluffs 1
Dallas 1
Delhi 1
Dublin 1
Duncan 1
Düsseldorf 1
Enfield 1
Falkenstein 1
Foshan 1
Guangzhou 1
Guatemala City 1
Hebei 1
Igrejinha 1
Indaiatuba 1
Itabira 1
Itamonte 1
Itapevi 1
Totale 623
Nome #
V804M RET MUTATION AND VANDETANIB RESPONSE IN METASTATIC MEDULLARY THYROID CANCER 183
Mutazione V804M di RET nel carcinoma midollare della tiroide e risposta al trattamento con vandetanib 133
null 122
The Mutation Profile Of Medullary Thyroid Carcinoma Can Be Different In Primary And Metastatic Tissues 107
Clinical Impact Of Ret Genetic Screening Of In The Management Of Medullary Thyroid Carcinoma (MTC) Patients: 20 Years Of Experience 107
Predictors Of Vandetanib Response In The Locally Advanced Or Metastatic Medullary Thyroid Cancer: A Single Center Experience 97
A novel fusion RET/PTC3 involving NCOA4 and RET genes in a pediatric case of Papillary Thyroid Carcinoma 82
Genetic heterogeneity of Medullary Thyroid Carcinoma 67
Whole Exome Sequencing of Medullary Thyroid Carcinomas did not identify oncogenic drivers alternative to RET and RAS genes 59
Totale 957
Categoria #
all - tutte 2.832
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.832


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 0 0 0 0 0 0 0 0 0 0 1
2020/202138 6 3 4 2 0 4 2 3 2 0 4 8
2021/202287 0 5 4 6 20 11 2 3 5 2 7 22
2022/2023175 30 23 15 4 8 16 3 9 51 0 13 3
2023/2024108 2 6 9 4 10 31 10 14 0 5 5 12
2024/2025261 1 15 5 21 32 33 14 16 18 35 20 51
Totale 957